hydroxyindoleacetic acid has been researched along with Gastrinoma in 8 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Gastrinoma: A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 7.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 3.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| " In this study we examined the effects of two agents that promote cellular differentiation, sodium butyrate and hexamethylene bisacetamide, on the in vitro growth and secretory responses of a human pancreatic carcinoid (BON) and human gastrinoma (PT-2 and PT-SM) cell lines that have been established in our laboratory." | 3.68 | Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells. ( Beauchamp, RD; Haber, BE; Hsieh, J; Ishizuka, J; Karp, G; Parekh, D; Rajaraman, S; Thompson, JC; Townsend, CM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Toole, D | 1 |
| Grossman, A | 1 |
| Gross, D | 1 |
| Delle Fave, G | 1 |
| Barkmanova, J | 1 |
| O'Connor, J | 1 |
| Pape, UF | 1 |
| Plöckinger, U | 1 |
| Bashir, S | 1 |
| Gibril, F | 1 |
| Ojeaburu, JV | 1 |
| Asgharian, B | 1 |
| Entsuah, LK | 1 |
| Ferraro, G | 1 |
| Crafa, P | 1 |
| Bordi, C | 1 |
| Jensen, RT | 1 |
| Nold, R | 1 |
| Frank, M | 1 |
| Kajdan, U | 1 |
| Trost, U | 1 |
| Klose, KJ | 1 |
| Arnold, R | 1 |
| Eriksson, B | 1 |
| Janson, ET | 1 |
| Bax, ND | 1 |
| Mignon, M | 1 |
| Morant, R | 1 |
| Opolon, P | 1 |
| Rougier, P | 1 |
| Oberg, KE | 1 |
| Nobels, FR | 1 |
| Kwekkeboom, DJ | 1 |
| Coopmans, W | 1 |
| Schoenmakers, CH | 1 |
| Lindemans, J | 1 |
| De Herder, WW | 1 |
| Krenning, EP | 1 |
| Bouillon, R | 1 |
| Lamberts, SW | 1 |
| Blanchin, M | 1 |
| James-Deidier, A | 1 |
| Chaumet-Riffaud, PD | 1 |
| Chayvialle, JA | 1 |
| Parekh, D | 1 |
| Ishizuka, J | 1 |
| Townsend, CM | 1 |
| Haber, BE | 1 |
| Beauchamp, RD | 1 |
| Rajaraman, S | 1 |
| Karp, G | 1 |
| Hsieh, J | 1 |
| Thompson, JC | 1 |
| Creutzfeldt, W | 1 |
| Bartsch, HH | 1 |
| Jacubaschke, U | 1 |
| Stöckmann, F | 1 |
3 trials available for hydroxyindoleacetic acid and Gastrinoma
| Article | Year |
|---|---|
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Biomarkers, | 1996 |
[Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Female; France; Gastrinoma; Glucagonoma; Humans; Hydroxyindoleacetic | 1992 |
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.
Topics: Aged; Carcinoid Tumor; Drug Evaluation; Female; Gastrinoma; Gastrointestinal Neoplasms; Humans; Hydr | 1991 |
5 other studies available for hydroxyindoleacetic acid and Gastrinoma
| Article | Year |
|---|---|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
Topics: Biomarkers; Chromogranin A; Fasting; Gastrinoma; Humans; Hydroxyindoleacetic Acid; Hypoglycemia; Ins | 2009 |
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoid Tumor; Chromogranin A; Chromogr | 2002 |
[Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha].
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Gastrinoma; Gastrins; Gastrointestinal Neoplas | 1994 |
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Chromo | 1997 |
Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells.
Topics: 5-Hydroxytryptophan; Acetamides; Analysis of Variance; Butyrates; Butyric Acid; Carcinoid Tumor; Cel | 1991 |